Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DE-PS02-08ER-08-01 | Other Grant/Funding Number | Department of Energy | |
| CIRMNo. RT1-01126-1 | Other Grant/Funding Number | California Institute for Regenerative Medicine | |
| 10-000269 | Other Identifier | UCLA Medical IRB#2 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patients with cancer | |||
| patients with autoimmune diseases | |||
| healthy subjects |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
patients with cancer, autoimmune diseases and healthy subjects
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christiaan Schiepers, M.D. Ph.D | University of California, Los Angeles | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UCLA | Los Angeles | California | 90095 | United States |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided